Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a group of drugs FDA-approved to treat low blood sugar in adults with type 2 diabetes.
Invokana can cause impaired kidney function, heart problems, bone fractures, and other health complications and ketoacidosis
The Invokana use have led patients to be injured. These injuries include, but NEVER are limited to the following;
-Confusion or difficulty concentrating
-Unusual fatigue or sleepiness
-Dry or flushed skin
Other Injuries Include: